Bibby, B A S, Thiruthaneeswaran, N, Yang, L, Pereira, R R, More, E, McArt, D G, O'Reilly, P, Bristow, R G, Williams, K J, Choudhury, A & West, C M L 2021, ' Repurposing FDA approved drugs as radiosensitizers for treating hypoxic prostate cancer ', BMC urology, vol. 21, no. 1, 96 . https://doi.org/10.1186/s12894-021-00856-x BMC Urology Bibby, B A S, Thiruthaneeswaran, N, Yang, L, Pereira, R R, More, E, McArt, D G, O'Reilly, P, Bristow, R G, Williams, K J, Choudhury, A & West, C M L 2021, ' Repurposing FDA approved drugs as radiosensitizers for treating hypoxic prostate cancer ', BMC Urology, vol. 21, no. 1, pp. 96 . https://doi.org/10.1186/s12894-021-00856-x BMC Urology, Vol 21, Iss 1, Pp 1-11 (2021)
Tran, M G B, Bibby, B A S, Yang, L, Lo, F, Warren, A Y, Shukla, D, Osborne, M, Hadfield, J, Carroll, T, Stark, R, Scott, H, Ramos-Montoya, A, Massie, C, Maxwell, P, West, C M L, Mills, I G & Neal, D E 2020, ' Independence of HIF1a and androgen signaling pathways in prostate cancer ', BMC Cancer, vol. 20, no. 1, pp. 469 . https://doi.org/10.1186/s12885-020-06890-6 BMC Cancer, Vol 20, Iss 1, Pp 1-12 (2020) BMC Cancer